The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global legionella testing market was valued at US$ 261 Million in 2021.
We expect the global legionella testing market to exhibit a CAGR of 8.38% during 2022-2027.
The rising development of legionella infection among the geriatric population, coupled with the growing
awareness towards the presence of effective diagnostic tests and treatments for legionella, is primarily
driving the global legionella testing market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of legionella testing
to identify some of the severe side-effects of the coronavirus infection, such as pneumonia.
Based on the application, the global legionella testing market has been segmented into water testing
and IVD testing. Currently, water testing holds the majority of the market share.
Based on the end user, the global legionella testing market can be divided into diagnostic laboratories,
hospitals and clinics, and others. Among these, diagnostic laboratories currently account for the largest
On a regional level, the market has been classified into Europe, North America, Asia Pacific, Latin
America, and Middle East and Africa, where Europe currently dominates the global market.
Some of the major players in the global legionella testing market include Abbott Laboratories, Becton,
Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc, Eiken Chemical Co. Ltd, Quidel
Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at